Mesenchymal stem or stromal cells from amnion and umbilical cord tissue and their potential for clinical applications

Cells

Volumn 1, Issue 4, 2012, Pages 1061-1088

  Lindenmair, Andrea ^a,b   Hatlapatka, Tim ^c   Kollwig, Gregor ^c   Hennerbichler, Simone ^b,d   Gabriel, Christian ^b,d   Wolbank, Susanne ^a,b   Redl, Heinz ^a,b   Kasper, Cornelia ^c  

^a LUDWIG BOLTZMANN INSTITUTE FOR EXPERIMENTAL AND CLINICAL TRAUMATOLOGY   (Austria)

^b AUSTRIAN CLUSTER FOR TISSUE REGENERATION   (Austria)

^c UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

^d Red Cross Blood Transfusion Service of Upper Austria   (Austria)

Author keywords

Amnion; Clinical applications; Mesenchymal stem cell; Mesenchymal stromal cell; MSC; Umbilical cord

Indexed keywords

5' NUCLEOTIDASE; ACTIVIN A; ADAPALENE; ALBUMIN; ALKALINE PHOSPHATASE; ALPHA 1 ANTITRYPSIN; ALPHA FETOPROTEIN; ANGIOPOIETIN RECEPTOR; BETA1 INTEGRIN; BONE MORPHOGENETIC PROTEIN 2; CD133 ANTIGEN; CD14 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; DESMIN; ENDOGLIN; FIBROBLAST GROWTH FACTOR 2; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA; MICROSOMAL AMINOPEPTIDASE; MYOD PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; OSTEOCALCIN; STAGE SPECIFIC EMBRYO ANTIGEN 4; THY 1 ANTIGEN; UNINDEXED DRUG; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VON WILLEBRAND FACTOR;

AMNION; BONE MARROW; CELL DIFFERENTIATION; CELL EXPANSION; CELL IMMORTALIZATION; CELL ISOLATION; CELL LINEAGE; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED CLINICAL TRIAL (TOPIC); FLOW CYTOMETRY; HUMAN; IMMUNOCYTOCHEMISTRY; IMMUNOLOGY; IMMUNOMODULATION; MESENCHYMAL STEM CELL; MESENCHYMAL STROMA CELL; MULTICENTER STUDY (TOPIC); NONHUMAN; PHASE 2 CLINICAL TRIAL (TOPIC); PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; UMBILICAL CORD;

EID: 84888179210     PISSN: None     EISSN: 20734409     Source Type: Journal    
DOI: 10.3390/cells1041061     Document Type: Review

References (154)

1. Alviano, F.; Fossati, V.; Marchionni, C.; Arpinati, M.; Bonsi, L.; Franchina, M.; Lanzoni, G.; Cantoni, S.; Cavallini, C.; Bianchi, F.; et al. Term amniotic membrane is a high throughput source for multipotent mesenchymal stem cells with the ability to differentiate into endothelial cells in vitro. BMC. Dev. Biol. 2007, 7, 11.
2. Bilic, G.; Zeisberger, S.M.; Mallik, A.S.; Zimmermann, R.; Zisch, A.H. Comparative characterization of cultured human term amnion epithelial and mesenchymal stromal cells for application in cell therapy. Cell Transplant. 2008, 17, 955-968.
3. Cargnoni, A.; Ressel, L.; Rossi, D.; Poli, A.; Arienti, D.; Lombardi, G.; Parolini, O. Conditioned medium from amniotic mesenchymal tissue cells reduces progression of bleomycin-induced lung fibrosis. Cytotherapy 2012, 14, 153-161.
4. Diaz-Prado, S.; Muinos-Lopez, E.; Hermida-Gomez, T.; Rendal-Vazquez, M.E.; Fuentes-Boquete, I.; de Toro, F.J.; Blanco, F.J. Multilineage differentiation potential of cells isolated from the human amniotic membrane. J. Cell Biochem. 2010, 111, 846-857.
5. Diaz-Prado, S.; Muinos-Lopez, E.; Hermida-Gomez, T.; Cicione, C.; Rendal-Vazquez, M.E.; Fuentes-Boquete, I.; de Toro, F.J.; Blanco, F.J. Human amniotic membrane as an alternative source of stem cells for regenerative medicine. Differentiation 2011, 81, 162-171.
6. Evangelista, M.; Soncini, M.; Parolini, O. Placenta-derived stem cells: New hope for cell therapy? Cytotechnology 2008, 58, 33-42.
7. Ilancheran, S.; Moodley, Y.; Manuelpillai, U. Human fetal membranes: A source of stem cells for tissue regeneration and repair? Placenta 2009, 30, 2-10.
8. In 't Anker, P.S.; Scherjon, S.A.; Kleijburg-van der Keur, C.; de Groot-Swings, G.M.; Claas, F.H.; Fibbe, W.E.; Kanhai, H.H. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells 2004, 22, 1338-1345.
9. Insausti, C.L.; Blanquer, M.; Bleda, P.; Iniesta, P.; Majado, M.J.; Castellanos, G.; Moraleda, J.M. The amniotic membrane as a source of stem cells. Histol. Histopathol. 2010, 25, 91-98.
10. Kang, J.W.; Koo, H.C.; Hwang, S.Y.; Kang, S.K.; Ra, J.C.; Lee, M.H.; Park, Y.H., Immunomodulatory effects of human amniotic membrane-derived mesenchymal stem cells. J. Vet. Sci. 2012, 13, 23-31.
11. Kim, J.; Park, S.; Kang, H.M.; Ahn, C.W.; Kwon, H.C.; Song, J.H.; Lee, Y.J.; Lee, K.H.; Yang, H.; Baek, S.Y.; et al. Human insulin secreted from insulinogenic xenograft restores normoglycemia in type i diabetic mice without immunosuppression. Cell Transplant. 2012, doi: 10.3727/096368912X636803.
12. König, J.; Huppertz, B.; Desoye, G.; Parolini, O.; Frohlich, J.D.; Weiss, G.; Dohr, G.; Sedlmayr, P.; Lang, I. Amnion-derived mesenchymal stromal cells show angiogenic properties but resist differentiation into mature endothelial cells. Stem Cells Dev. 2012, 21, 1309-1320.
13. Kronsteiner, B.; Wolbank, S.; Peterbauer, A.; Hackl, C.; Redl, H.; van, G.M.; Gabriel, C. Human mesenchymal stem cells from adipose tissue and amnion influence t-cells depending on stimulation method and presence of other immune cells. Stem Cells Dev. 2011, 20, 2115-2126.
14. Lisi, A.; Briganti, E.; Ledda, M.; Losi, P.; Grimaldi, S.; Marchese, R.; Soldani, G., A combined synthetic-fibrin scaffold supports growth and cardiomyogenic commitment of human placental derived stem cells. PLoS One 2012, 7, e34284.
15. Magatti, M.; De, M.S.; Vertua, E.; Nassauto, C.; Albertini, A.; Wengler, G.S.; Parolini, O. Amniotic mesenchymal tissue cells inhibit dendritic cell differentiation of peripheral blood and amnion resident monocytes. Cell Transplant. 2009, 18, 899-914.
16. Manuelpillai, U.; Moodley, Y.; Borlongan, C.V.; Parolini, O. Amniotic membrane and amniotic cells: Potential therapeutic tools to combat tissue inflammation and fibrosis? Placenta 2011, 32 (Suppl. 4), S320-S325.
17. Miki, T.; Strom, S.C. Amnion-derived pluripotent/multipotent stem cells. Stem Cell Rev. 2006, 2, 133-142.
18. Paracchini, V.; Carbone, A.; Colombo, F.; Castellani, S.; Mazzucchelli, S.; Gioia, S.D.; Degiorgio, D.; Seia, M.; Porretti, L.; Colombo, C.; et al. Amniotic mesenchymal stem cells: A new source for hepatocyte-like cells and induction of cftr expression by coculture with cystic fibrosis airway epithelial cells. J. Biomed. Biotechnol. 2012, 2012, 575471.
19. Parolini, O.; Alviano, F.; Bagnara, G.P.; Bilic, G.; Buhring, H.J.; Evangelista, M.; Hennerbichler, S.; Liu, B.; Magatti, M.; Mao, N.; et al. Concise review: Isolation and characterization of cells from human term placenta: Outcome of the first international workshop on placenta derived stem cells. Stem Cells 2008, 26, 300-311.
20. Roubelakis, M.G.; Trohatou, O.; Anagnou, N.P. Amniotic fluid and amniotic membrane stem cells: Marker discovery. Stem Cells Int. 2012, 2012, 107836.
21. Stadler, G.; Hennerbichler, S.; Lindenmair, A.; Peterbauer, A.; Hofer, K.; van, G.M.; Gabriel, C.; Redl, H.; Wolbank, S. Phenotypic shift of human amniotic epithelial cells in culture is associated with reduced osteogenic differentiation in vitro. Cytotherapy. 2008, 10, 743-752.
22. Tamagawa, T.; Ishiwata, I.; Sato, K.; Nakamura, Y. Induced in vitro differentiation of pancreaticlike cells from human amnion-derived fibroblast-like cells. Hum. Cell 2009, 22, 55-63.
23. Wei, J.P.; Nawata, M.; Wakitani, S.; Kametani, K.; Ota, M.; Toda, A.; Konishi, I.; Ebara, S.; Nikaido, T. Human amniotic mesenchymal cells differentiate into chondrocytes. Cloning Stem Cells 2009, 11, 19-26.
24. Wolbank, S.; Stadler, G.; Peterbauer, A.; Gillich, A.; Karbiener, M.; Streubel, B.; Wieser, M.; Katinger, H.; van, G.M.; Redl, H.; et al. Telomerase immortalized human amnion-and adiposederived mesenchymal stem cells: Maintenance of differentiation and immunomodulatory characteristics. Tissue Eng. Part A 2009, 15, 1843-1854.
25. Zhao, P.; Ise, H.; Hongo, M.; Ota, M.; Konishi, I.; Nikaido, T. Human amniotic mesenchymal cells have some characteristics of cardiomyocytes. Transplantation 2005, 79, 528-535.
26. Covas, D.T.; Siufi, J.L.; Silva, A.R.; Orellana, M.D. Isolation and culture of umbilical vein mesenchymal stem cells. Braz. J. Med. Biol. Res. 2003, 36, 1179-1183.
27. Panepucci, R.A.; Siufi, J.L.; Silva, W.A., Jr.; Proto-Siquiera, R.; Neder, L.; Orellana, M.; Rocha, V.; Covas, D.T.; Zago, M.A. Comparison of gene expression of umbilical cord vein and bone marrow-derived mesenchymal stem cells. Stem Cells 2004, 22, 1263-1278.
28. Romanov, Y.A.; Svintsitskaya, V.A.; Smirnov, V.N. Searching for alternative sources of postnatal human mesenchymal stem cells: Candidate msc-like cells from umbilical cord. Stem Cells 2003, 21, 105-110.
29. Bailey, M.M.; Wang, L.; Bode, C.J.; Mitchell, K.E.; Detamore, M.S. A comparison of human umbilical cord matrix stem cells and temporomandibular joint condylar chondrocytes for tissue engineering temporomandibular joint condylar cartilage. Tissue Eng 2007, 13, 2003-2010.
30. Conconi, M.T.; Burra, P.; Di Liddo, R.; Calore, C.; Turetta, M.; Bellini, S.; Bo, P.; Nussdorfer, G.G.; Parnigotto, P.P. Cd105(+) cells from wharton's jelly show in vitro and in vivo myogenic differentiative potential. Int. J. Mol. Med. 2006, 18, 1089-1096.
31. Fu, Y.S.; Cheng, Y.C.; Lin, M.Y.; Cheng, H.; Chu, P.M.; Chou, S.C.; Shih, Y.H.; Ko, M.H.; Sung, M.S. Conversion of human umbilical cord mesenchymal stem cells in wharton's jelly to dopaminergic neurons in vitro: Potential therapeutic application for parkinsonism. Stem Cells 2006, 24, 115-124.
32. Fu, Y.S.; Shih, Y.T.; Cheng, Y.C.; Min, M.Y. Transformation of human umbilical mesenchymal cells into neurons in vitro. J. Biomed. Sci. 2004, 11, 652-660.
33. Karahuseyinoglu, S.; Cinar, O.; Kilic, E.; Kara, F.; Akay, G.G.; Demiralp, D.O.; Tukun, A.; Uckan, D.; Can, A. Biology of stem cells in human umbilical cord stroma: In situ and in vitro surveys. Stem Cells 2007, 25, 319-331.
34. Lund, R.D.; Wang, S.; Lu, B.; Girman, S.; Holmes, T.; Sauve, Y.; Messina, D.J.; Harris, I.R.; Kihm, A.J.; Harmon, A.M.; et al. Cells isolated from umbilical cord tissue rescue photoreceptors and visual functions in a rodent model of retinal disease. Stem Cells 2007, 25, 602-611.
35. Ma, L.; Feng, X.Y.; Cui, B.L.; Law, F.; Jiang, X.W.; Yang, L.Y.; Xie, Q.D.; Huang, T.H. Human umbilical cord wharton's jelly-derived mesenchymal stem cells differentiation into nerve-like cells. Chin. Med. J. (Engl) 2005, 118, 1987-1993.
36. Mitchell, K.E.; Weiss, M.L.; Mitchell, B.M.; Martin, P.; Davis, D.; Morales, L.; Helwig, B.; Beerenstrauch, M.; Abou-Easa, K.; Hildreth, T.; et al. Matrix cells from wharton's jelly form neurons and glia. Stem Cells 2003, 21, 50-60.
37. Schmidt, D.; Mol, A.; Odermatt, B.; Neuenschwander, S.; Breymann, C.; Gossi, M.; Genoni, M.; Zund, G.; Hoerstrup, S.P. Engineering of biologically active living heart valve leaflets using human umbilical cord-derived progenitor cells. Tissue. Eng. 2006, 12, 3223-3232.
38. Wang, H.S.; Hung, S.C.; Peng, S.T.; Huang, C.C.; Wei, H.M.; Guo, Y.J.; Fu, Y.S.; Lai, M.C.; Chen, C.C. Mesenchymal stem cells in the wharton's jelly of the human umbilical cord. Stem Cells 2004, 22, 1330-1337.
39. Weiss, M.L.; Medicetty, S.; Bledsoe, A.R.; Rachakatla, R.S.; Choi, M.; Merchav, S.; Luo, Y.; Rao, M.S.; Velagaleti, G.; Troyer, D. Human umbilical cord matrix stem cells: Preliminary characterization and effect of transplantation in a rodent model of parkinson's disease. Stem Cells 2006, 24, 781-792.
40. Baksh, D.; Yao, R.; Tuan, R.S. Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells 2007, 25, 1384-1392.
41. Sarugaser, R.; Lickorish, D.; Baksh, D.; Hosseini, M.M.; Davies, J.E. Human umbilical cord perivascular (hucpv) cells: A source of mesenchymal progenitors. Stem Cells 2005, 23, 220-229.
42. Bieback, K.; Kluter, H. Mesenchymal stromal cells from umbilical cord blood. Curr. Stem. Cell Res. Ther. 2007, 2, 310-323.
43. Gang, E.J.; Jeong, J.A.; Han, S.; Yan, Q.; Jeon, C.J.; Kim, H. In vitro endothelial potential of human uc blood-derived mesenchymal stem cells. Cytotherapy 2006, 8, 215-227.
44. Gang, E.J.; Jeong, J.A.; Hong, S.H.; Hwang, S.H.; Kim, S.W.; Yang, I.H.; Ahn, C.; Han, H.; Kim, H. Skeletal myogenic differentiation of mesenchymal stem cells isolated from human umbilical cord blood. Stem Cells 2004, 22, 617-624.
45. Hou, L.; Cao, H.; Wang, D.; Wei, G.; Bai, C.; Zhang, Y.; Pei, X., Induction of umbilical cord blood mesenchymal stem cells into neuron-like cells in vitro. Int. J. Hematol. 2003, 78, 256-261.
46. Lee, O.K.; Kuo, T.K.; Chen, W.M.; Lee, K.D.; Hsieh, S.L.; Chen, T.H. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 2004, 103, 1669-1675.
47. Bilic, G.; Ochsenbein-Kolble, N.; Hall, H.; Huch, R.; Zimmermann, R. In vitro lesion repair by human amnion epithelial and mesenchymal cells. Am. J. Obstet. Gynecol. 2004, 190, 87-92.
48. Casey, M.L.; MacDonald, P.C. Keratinocyte growth factor expression in the mesenchymal cells of human amnion. J. Clin. Endocrinol. Metab 1997, 82, 3319-3323.
49. Magatti, M.; De, M.S.; Vertua, E.; Gibelli, L.; Wengler, G.S.; Parolini, O. Human amnion mesenchyme harbors cells with allogeneic t-cell suppression and stimulation capabilities. Stem Cells 2008, 26, 182-192.
50. Portmann-Lanz, C.B.; Schoeberlein, A.; Huber, A.; Sager, R.; Malek, A.; Holzgreve, W.; Surbek, D.V. Placental mesenchymal stem cells as potential autologous graft for pre-and perinatal neuroregeneration. Am. J. Obstet. Gynecol. 2006, 194, 664-673.
51. Sakuragawa, N.; Kakinuma, K.; Kikuchi, A.; Okano, H.; Uchida, S.; Kamo, I.; Kobayashi, M.; Yokoyama, Y. Human amnion mesenchyme cells express phenotypes of neuroglial progenitor cells. J. Neurosci. Res. 2004, 78, 208-214.
52. Soncini, M.; Vertua, E.; Gibelli, L.; Zorzi, F.; Denegri, M.; Albertini, A.; Wengler, G.S.; Parolini, O. Isolation and characterization of mesenchymal cells from human fetal membranes. J. Tissue Eng. Regen. Med. 2007, 1, 296-305.
53. Tamagawa, T.; Oi, S.; Ishiwata, I.; Ishikawa, H.; Nakamura, Y. Differentiation of mesenchymal cells derived from human amniotic membranes into hepatocyte-like cells in vitro. Hum. Cell 2007, 20, 77-84.
54. Whittle, W.L.; Gibb, W.; Challis, J.R. The characterization of human amnion epithelial and mesenchymal cells: The cellular expression, activity and glucocorticoid regulation of prostaglandin output. Placenta 2000, 21, 394-401.
55. Wolbank, S.; Peterbauer, A.; Fahrner, M.; Hennerbichler, S.; van, G.M.; Stadler, G.; Redl, H.; Gabriel, C. Dose-dependent immunomodulatory effect of human stem cells from amniotic membrane: A comparison with human mesenchymal stem cells from adipose tissue. Tissue Eng 2007, 13, 1173-1183.
56. Sudo, K.; Kanno, M.; Miharada, K.; Ogawa, S.; Hiroyama, T.; Saijo, K.; Nakamura, Y. Mesenchymal progenitors able to differentiate into osteogenic, chondrogenic, and/or adipogenic cells in vitro are present in most primary fibroblast-like cell populations. Stem Cells 2007, 25, 1610-1617.
57. Manochantr, S.; Tantrawatpan, C.; Kheolamai, P.; Pratya, Y.; Supokawej, A.; Issaragrisil, S. Isolation, characterization and neural differentiation potential of amnion derived mesenchymal stem cells. J. Med. Assoc. Thai. 2010, 93 (Suppl. 7), S183-S191.
58. Tsuji, H.; Miyoshi, S.; Ikegami, Y.; Hida, N.; Asada, H.; Togashi, I.; Suzuki, J.; Satake, M.; Nakamizo, H.; Tanaka, M.; et al. Xenografted human amniotic membrane-derived mesenchymal stem cells are immunologically tolerated and transdifferentiated into cardiomyocytes. Circ. Res. 2010, 106, 1613-1623.
59. Miki, T.; Mitamura, K.; Ross, M.A.; Stolz, D.B.; Strom, S.C. Identification of stem cell markerpositive cells by immunofluorescence in term human amnion. J. Reprod. Immunol. 2007, 75, 91-96.
60. Bilic, G.; Hall, H.; Bittermann, A.G.; Zammeretti, P.; Burkhart, T.; Ochsenbein-Kolble, N.; Zimmermann, R. Human preterm amnion cells cultured in 3-dimensional collagen i and fibrin matrices for tissue engineering purposes. Am. J. Obstet. Gynecol. 2005, 193, 1724-1732.
61. Pasquinelli, G.; Tazzari, P.; Ricci, F.; Vaselli, C.; Buzzi, M.; Conte, R.; Orrico, C.; Foroni, L.; Stella, A.; Alviano, F.; et al. Ultrastructural characteristics of human mesenchymal stromal (stem) cells derived from bone marrow and term placenta. Ultrastruct. Pathol. 2007, 31, 23-31.
62. Kadam, S.S.; Bhonde, R.R. Islet neogenesis from the constitutively nestin expressing human umbilical cord matrix derived mesenchymal stem cells. Islets 2010, 2, 112-120.
63. Ishige, I.; Nagamura-Inoue, T.; Honda, M.; Harnprasopwat, R.; Kido, M.; Sugimoto, M.; Nakauchi, H.; Tojo, A. Comparison of mesenchymal stem cells derived from arterial, venous, and wharton's jelly explants of human umbilical cord. Int. J. Hematol. 2009, 90, 261.
64. La Rocca, G.; Anzalone, R.; Corrao, S.; Magno, F.; Loria, T.; Lo Iacono, M.; Di Stefano, A.; Giannuzzi, P.; Marasa, L.; Cappello, F.; et al. Isolation and characterization of oct-4+/hla-g+ mesenchymal stem cells from human umbilical cord matrix: Differentiation potential and detection of new markers. Histochem. Cell. Biol. 2009, 131, 267-282.
65. Lu, L.L.; Liu, Y.J.; Yang, S.G.; Zhao, Q.J.; Wang, X.; Gong, W.; Han, Z.B.; Xu, Z.S.; Lu, Y.X.; Liu, D.; et al. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica 2006, 91, 1017-1026.
66. Schneider, R.K.; Pullen, A.; Kramann, R.; Bornemann, J.; Knuchel, R.; Neuss, S.; Perez-Bouza, A. Long-term survival and characterisation of human umbilical cord-derived mesenchymal stem cells on dermal equivalents. Differentiation 2010, 79, 182-193.
67. Tsagias, N.; Koliakos, I.; Karagiannis, V.; Eleftheriadou, M.; Koliakos, G.G. Isolation of mesenchymal stem cells using the total length of umbilical cord for transplantation purposes. Transfus. Med. 2011, 21, 253-261.
68. Gonzalez, R.; Griparic, L.; Umana, M.; Burgee, K.; Vargas, V.; Nasrallah, R.; Silva, F.; Patel, A. An efficient approach to isolation and characterization of pre-and postnatal umbilical cord lining stem cells for clinical applications. Cell Transplant. 2010, 19, 1439-1449.
69. Kadner, A.; Zund, G.; Maurus, C.; Breymann, C.; Yakarisik, S.; Kadner, G.; Turina, M.; Hoerstrup, S.P. Human umbilical cord cells for cardiovascular tissue engineering: A comparative study. Eur. J. Cardiothorac. Surg. 2004, 25, 635-641.
70. Majore, I.; Moretti, P.; Stahl, F.; Hass, R.; Kasper, C. Growth and differentiation properties of mesenchymal stromal cell populations derived from whole human umbilical cord. Stem. Cell. Rev. 2010, 7, 17-31.
71. Petsa, A.; Gargani, S.; Felesakis, A.; Grigoriadis, N.; Grigoriadis, I. Effectiveness of protocol for the isolation of wharton's jelly stem cells in large-scale applications. In vitro Cell. Dev. Biol. Anim. 2009, 45, 573-576.
72. Moretti, P.; Hatlapatka, T.; Marten, D.; Lavrentieva, A.; Majore, I.; Hass, R.; Kasper, C. Mesenchymal stromal cells derived from human umbilical cord tissues: Primitive cells with potential for clinical and tissue engineering applications. Adv. Biochem. Eng. Biotechnol. 2010, 123, 29-54.
73. Majore, I.; Moretti, P.; Hass, R.; Kasper, C. Identification of subpopulations in mesenchymal stem cell-like cultures from human umbilical cord. Cell. Commun. Signal. 2009, 7, 6.
74. Sivasubramaniyan, K.; Lehnen, D.; Ghazanfari, R.; Sobiesiak, M.; Harichandan, A.; Mortha, E.; Petkova, N.; Grimm, S.; Cerabona, F.; de Zwart, P.; et al. Phenotypic and functional heterogeneity of human bone marrow-and amnion-derived msc subsets. Ann. NY Acad. Sci. 2012, 1266, 94-106.
75. Battula, V.L.; Treml, S.; Bareiss, P.M.; Gieseke, F.; Roelofs, H.; de Zwart, P.; Muller, I.; Schewe, B.; Skutella, T.; Fibbe, W.E.; et al. Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against cd56, cd271, and mesenchymal stem cell antigen-1. Haematologica 2009, 94, 173-184.
76. Buhring, H.J.; Battula, V.L.; Treml, S.; Schewe, B.; Kanz, L.; Vogel, W. Novel markers for the prospective isolation of human msc. Ann. NY Acad. Sci. 2007, 1106, 262-271.
77. Gang, E.J.; Bosnakovski, D.; Figueiredo, C.A.; Visser, J.W.; Perlingeiro, R.C. Ssea-4 identifies mesenchymal stem cells from bone marrow. Blood 2007, 109, 1743-1751.
78. Kawanabe, N.; Murata, S.; Fukushima, H.; Ishihara, Y.; Yanagita, T.; Yanagita, E.; Ono, M.; Kurosaka, H.; Kamioka, H.; Itoh, T.; et al. Stage-specific embryonic antigen-4 identifies human dental pulp stem cells. Exp. Cell. Res. 2012, 318, 453-463.
79. Martinez, C.; Hofmann, T.J.; Marino, R.; Dominici, M.; Horwitz, E.M. Human bone marrow mesenchymal stromal cells express the neural ganglioside gd2: A novel surface marker for the identification of mscs. Blood 2007, 109, 4245-4248.
80. Xu, J.; Liao, W.; Gu, D.; Liang, L.; Liu, M.; Du, W.; Liu, P.; Zhang, L.; Lu, S.; Dong, C.; et al. Neural ganglioside gd2 identifies a subpopulation of mesenchymal stem cells in umbilical cord. Cell. Physiol. Biochem. 2009, 23, 415-424.
81. Cheng, H.; Qiu, L.; Ma, J.; Zhang, H.; Cheng, M.; Li, W.; Zhao, X.; Liu, K. Replicative senescence of human bone marrow and umbilical cord derived mesenchymal stem cells and their differentiation to adipocytes and osteoblasts. Mol. Biol. Rep. 2011, 38, 5161-5168.
82. Pittenger, M.F.; Mackay, A.M.; Beck, S.C.; Jaiswal, R.K.; Douglas, R.; Mosca, J.D.; Moorman, M.A.; Simonetti, D.W.; Craig, S.; Marshak, D.R. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284, 143-147.
83. Kim, S.W.; Zhang, H.Z.; Kim, C.E.; An, H.S.; Kim, J.M.; Kim, M.H. Amniotic mesenchymal stem cells have robust angiogenic properties and are effective in treating hindlimb ischaemia. Cardiovasc. Res. 2012, 93, 525-534.
84. Wei, J.P.; Zhang, T.S.; Kawa, S.; Aizawa, T.; Ota, M.; Akaike, T.; Kato, K.; Konishi, I.; Nikaido, T. Human amnion-isolated cells normalize blood glucose in streptozotocin-induced diabetic mice. Cell Transplant. 2003, 12, 545-552.
85. Tamagawa, T.; Ishiwata, I.; Ishikawa, H.; Nakamura, Y. Induced in-vitro differentiation of neural-like cells from human amnion-derived fibroblast-like cells. Hum. Cell 2008, 21, 38-45.
86. Chen, M.Y.; Lie, P.C.; Li, Z.L.; Wei, X. Endothelial differentiation of wharton's jelly-derived mesenchymal stem cells in comparison with bone marrow-derived mesenchymal stem cells. Exp. Hematol. 2009, 37, 629-640.
87. Ciavarella, S.; Dammacco, F.; De Matteo, M.; Loverro, G.; Silvestris, F. Umbilical cord mesenchymal stem cells: Role of regulatory genes in their differentiation to osteoblasts. Stem Cells Dev. 2009, 18, 1211-1220.
88. Covas, D.T.; Panepucci, R.A.; Fontes, A.M.; Silva, W.A., Jr.; Orellana, M.D.; Freitas, M.C.; Neder, L.; Santos, A.R.; Peres, L.C.; Jamur, M.C.; et al. Multipotent mesenchymal stromal cells obtained from diverse human tissues share functional properties and gene-expression profile with cd146+ perivascular cells and fibroblasts. Exp. Hematol. 2008, 36, 642-654.
89. Diao, Y.; Ma, Q.; Cui, F.; Zhong, Y. Human umbilical cord mesenchymal stem cells: Osteogenesis in vivo as seed cells for bone tissue engineering. J. Biomed. Mater. Res. A 2008, 91, 123-131.
90. Jo, C.H.; Kim, O.S.; Park, E.Y.; Kim, B.J.; Lee, J.H.; Kang, S.B.; Lee, J.H.; Han, H.S.; Rhee, S.H.; Yoon, K.S. Fetal mesenchymal stem cells derived from human umbilical cord sustain primitive characteristics during extensive expansion. Cell Tissue Res. 2008, 334, 423-433.
91. Kadam, S.S.; Tiwari, S.; Bhonde, R.R. Simultaneous isolation of vascular endothelial cells and mesenchymal stem cells from the human umbilical cord. In Vitro Cell Dev. Biol. Anim. 2009, 45, 23-27.
92. Kadivar, M.; Khatami, S.; Mortazavi, Y.; Shokrgozar, M.A.; Taghikhani, M.; Soleimani, M. In vitro cardiomyogenic potential of human umbilical vein-derived mesenchymal stem cells. Biochem. Biophys. Res. Commun. 2006, 340, 639-647.
93. Kestendjieva, S.; Kyurkchiev, D.; Tsvetkova, G.; Mehandjiev, T.; Dimitrov, A.; Nikolov, A.; Kyurkchiev, S. Characterization of mesenchymal stem cells isolated from the human umbilical cord. Cell. Biol. Int. 2008, 32, 724-732.
94. Liu, X.D.; Liu, B.; Li, X.S.; Mao, N. Isolation and identification of mesenchymal stem cells from perfusion of human umbilical cord vein. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2007, 15, 1019-1022.
95. Lu, L.L.; Song, Y.P.; Wei, X.D.; Fang, B.J.; Zhang, Y.L.; Li, Y.F. comparative characterization of mesenchymal stem cells from human umbilical cord tissue and bone marrow. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2008, 16, 140-146.
96. Martin-Rendon, E.; Sweeney, D.; Lu, F.; Girdlestone, J.; Navarrete, C.; Watt, S.M. 5-azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies. Vox Sang 2008, 95, 137-148.
97. Qiao, C.; Xu, W.; Zhu, W.; Hu, J.; Qian, H.; Yin, Q.; Jiang, R.; Yan, Y.; Mao, F.; Yang, H.; et al. Human mesenchymal stem cells isolated from the umbilical cord. Cell. Biol. Int. 2008, 32, 8-15.
98. Sudo, K.; Kanno, M.; Miharada, K.; Ogawa, S.; Hiroyama, T.; Saijo, K.; Nakamura, Y. Mesenchymal progenitors able to differentiate into osteogenic, chondrogenic, and/or adipogenic cells in vitro are present in most primary fibroblast-like cell populations. Stem Cells 2007, 25, 1610-1617.
99. Suzdal'tseva, Y.G.; Burunova, V.V.; Vakhrushev, I.V.; Yarygin, V.N.; Yarygin, K.N. Capability of human mesenchymal cells isolated from different sources to differentiation into tissues of mesodermal origin. Bull. Exp. Biol. Med. 2007, 143, 114-121.
100. Tian, X.; Fu, R.Y.; Chen, Y.; Yuan, L.X. isolation of multipotent mesenchymal stem cells from the tissue of umbilical cord for osteoblasts and adipocytes differentiation. Sichuan Da Xue Xue Bao Yi Xue Ban 2008, 39, 26-29.
101. Wu, K.H.; Zhou, B.; Lu, S.H.; Feng, B.; Yang, S.G.; Du, W.T.; Gu, D.S.; Han, Z.C.; Liu, Y.L. In vitro and in vivo differentiation of human umbilical cord derived stem cells into endothelial cells. J. Cell. Biochem. 2007, 100, 608-616.
102. Zhang, Z.Y.; Teoh, S.H.; Chong, M.S.; Schantz, J.T.; Fisk, N.M.; Choolani, M.A.; Chan, J. Superior osteogenic capacity for bone tissue engineering of fetal compared with perinatal and adult mesenchymal stem cells. Stem Cells 2009, 27, 126-137.
103. Farias, V.A.; Linares-Fernandez, J.L.; Penalver, J.L.; Paya Colmenero, J.A.; Ferron, G.O.; Duran, E.L.; Fernandez, R.M.; Olivares, E.G.; O'Valle, F.; Puertas, A.; et al. Human umbilical cord stromal stem cell express cd10 and exert contractile properties. Placenta 2010, 32, 86-95.
104. Montanucci, P.; Basta, G.; Pescara, T.; Pennoni, I.; Di Giovanni, F.; Calafiore, R. New simple and rapid method for purification of mesenchymal stem cells from the human umbilical cord wharton jelly. Tissue Eng. Part A 2011, 17, 2651-2661.
105. Salehinejad, P.; Alitheen, N.B.; Nematollahi-Mahani, S.N.; Ali, A.M.; Omar, A.R.; Janzamin, E.; Hajghani, M. Effect of culture media on expansion properties of human umbilical cord matrixderived mesenchymal cells. Cytotherapy 2012, 14, 948-953.
106. Struys, T.; Moreels, M.; Martens, W.; Donders, R.; Wolfs, E.; Lambrichts, I. Ultrastructural and immunocytochemical analysis of multilineage differentiated human dental pulp-and umbilical cord-derived mesenchymal stem cells. Cells Tissues Organs 2011, 193, 366-378.
107. Xu, Z.F.; Pan, A.Z.; Yong, F.; Shen, C.Y.; Chen, Y.W.; Wu, R.H. Human umbilical mesenchymal stem cell and its adipogenic differentiation: Profiling by nuclear magnetic resonance spectroscopy. World J. Stem. Cells 2012, 4, 21-27.
108. Qiao, S.M.; Chen, G.H.; Wang, Y.; Wu, D.P. ultrastructure of human umbilical cord mesenchymal stem cells. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2012, 20, 443-447.
109. Zhang, Y.N.; Lie, P.C.; Wei, X. Differentiation of mesenchymal stromal cells derived from umbilical cord wharton's jelly into hepatocyte-like cells. Cytotherapy 2009, 11, 548-558.
110. Honsawek, S.; Dhitiseith, D.; Phupong, V. Effects of demineralized bone matrix on proliferation and osteogenic differentiation of mesenchymal stem cells from human umbilical cord. J. Med. Assoc. Thai 2006, 89 (Suppl. 3), S189-S195.
111. Hou, T.; Xu, J.; Wu, X.; Xie, Z.; Luo, F.; Zhang, Z.; Zeng, L. Umbilical cord wharton's jelly: A new potential cell source of mesenchymal stromal cells for bone tissue engineering. Tissue Eng Part A 2009, 15, 2325-2334.
112. Passeri, S.; Nocchi, F.; Lamanna, R.; Lapi, S.; Miragliotta, V.; Giannessi, E.; Abramo, F.; Stornelli, M.R.; Matarazzo, M.; Plenteda, D.; et al. Isolation and expansion of equine umbilical cord-derived matrix cells (eucmcs). Cell. Biol. Int. 2009, 33, 100-105.
113. Baba, K.; Yamazaki, Y.; Ikemoto, S.; Aoyagi, K.; Takeda, A.; Uchinuma, E. Osteogenic potential of human umbilical cord-derived mesenchymal stromal cells cultured with umbilical cord blood-derived autoserum. J. Craniomaxillofac. Surg. 2012, in press.
114. Kang, M.N.; Yoon, H.H.; Seo, Y.K.; Park, J.K. Effect of mechanical stimulation on the differentiation of cord stem cells. Connect. Tissue Res. 2012, 53, 149-159.
115. Xu, Y.; Meng, H.; Li, C.; Hao, M.; Wang, Y.; Yu, Z.; Li, Q.; Han, J.; Zhai, Q.; Qiu, L. Umbilical cord-derived mesenchymal stem cells isolated by a novel explantation technique can differentiate into functional endothelial cells and promote revascularization. Stem Cells Dev. 2010, 19, 1511-1522.
116. Pereira, W.C.; Khushnooma, I.; Madkaikar, M.; Ghosh, K. Reproducible methodology for the isolation of mesenchymal stem cells from human umbilical cord and its potential for cardiomyocyte generation. J. Tissue Eng. Regen. Med. 2008, 2, 394-399.
117. Qian, Q.; Qian, H.; Zhang, X.; Zhu, W.; Yan, Y.; Ye, S.; Peng, X.; Li, W.; Xu, Z.; Sun, L.; et al. 5-azacytidine induces cardiac differentiation of human umbilical cord-derived mesenchymal stem cells by activating extracellular regulated kinase. Stem Cells Dev. 2012, 21, 67-75.
118. Zhao, Z.; Chen, Z.; Zhao, X.; Pan, F.; Cai, M.; Wang, T.; Zhang, H.; Lu, J.R.; Lei, M. Sphingosine-1-phosphate promotes the differentiation of human umbilical cord mesenchymal stem cells into cardiomyocytes under the designated culturing conditions. J. Biomed. Sci. 2011, 18, 37.
119. Campard, D.; Lysy, P.A.; Najimi, M.; Sokal, E.M. Native umbilical cord matrix stem cells express hepatic markers and differentiate into hepatocyte-like cells. Gastroenterology 2008, 134, 833-848.
120. Zhao, Q.; Ren, H.; Li, X.; Chen, Z.; Zhang, X.; Gong, W.; Liu, Y.; Pang, T.; Han, Z.C. Differentiation of human umbilical cord mesenchymal stromal cells into low immunogenic hepatocyte-like cells. Cytotherapy 2009, 11, 414-426.
121. Wang, H.W.; Lin, L.M.; He, H.Y.; You, F.; Li, W.Z.; Huang, T.H.; Ma, G.X.; Ma, L. Human umbilical cord mesenchymal stem cells derived from wharton's jelly differentiate into insulinproducing cells in vitro. Chin. Med. J. (Engl) 2011, 124, 1534-1539.
122. Wang, H.S.; Shyu, J.F.; Shen, W.S.; Hsu, H.C.; Chi, T.C.; Chen, C.P.; Huang, S.W.; Shyr, Y.M.; Tang, K.T.; Chen, T.H. Transplantation of insulin-producing cells derived from umbilical cord stromal mesenchymal stem cells to treat nod mice. Cell Transplant. 2011, 20, 455-466.
123. Chao, K.C.; Chao, K.F.; Fu, Y.S.; Liu, S.H. Islet-like clusters derived from mesenchymal stem cells in wharton's jelly of the human umbilical cord for transplantation to control type 1 diabetes. PLoS ONE 2008, 3, e1451.
124. Wu, L.F.; Wang, N.N.; Liu, Y.S.; Wei, X. Differentiation of wharton's jelly primitive stromal cells into insulin-producing cells in comparison with bone marrow mesenchymal stem cells. Tissue Eng Part A 2009, 15, 2865-2873.
125. Chou, S.C.; Ko, T.L.; Fu, Y.Y.; Wang, H.W.; Fu, Y.S. Identification of genetic networks during mesenchymal stem cell transformation into neurons. Chin. J. Physiol. 2008, 51, 230-246.
126. Ma, L.; Cui, B.L.; Feng, X.Y.; Law, F.D.; Jiang, X.W.; Yang, L.Y.; Xie, Q.D.; Huang, T.H. biological characteristics of human umbilical cord-derived mesenchymal stem cells and their differentiation into neurocyte-like cells. Zhonghua Er Ke Za Zhi 2006, 44, 513-517.
127. Matsuse, D.; Kitada, M.; Kohama, M.; Nishikawa, K.; Makinoshima, H.; Wakao, S.; Fujiyoshi, Y.; Heike, T.; Nakahata, T.; Akutsu, H.; et al. Human umbilical cord-derived mesenchymal stromal cells differentiate into functional schwann cells that sustain peripheral nerve regeneration. J. Neuropathol. Exp. Neurol. 2010, 69, 973-985.
128. Cho, H.; Seo, Y.K.; Jeon, S.; Yoon, H.H.; Choi, Y.K.; Park, J.K. Neural differentiation of umbilical cord mesenchymal stem cells by sub-sonic vibration. Life Sci. 2012, 90, 591-599.
129. Chen, K.; Wang, D.; Du, W.T.; Han, Z.B.; Ren, H.; Chi, Y.; Yang, S.G.; Zhu, D.; Bayard, F.; Han, Z.C. Human umbilical cord mesenchymal stem cells huc-mscs exert immunosuppressive activities through a pge2-dependent mechanism. Clin. Immunol. 2010, 135, 448-458.
130. Weiss, M.L.; Anderson, C.; Medicetty, S.; Seshareddy, K.B.; Weiss, R.J.; VanderWerff, I.; Troyer, D.; McIntosh, K.R. Immune properties of human umbilical cord wharton's jelly-derived cells. Stem Cells 2008, 26, 2865-2874.
131. Zhou, C.; Yang, B.; Tian, Y.; Jiao, H.; Zheng, W.; Wang, J.; Guan, F. Immunomodulatory effect of human umbilical cord wharton's jelly-derived mesenchymal stem cells on lymphocytes. Cell Immunol. 2011, 272, 33-38.
132. Bailo, M.; Soncini, M.; Vertua, E.; Signoroni, P.B.; Sanzone, S.; Lombardi, G.; Arienti, D.; Calamani, F.; Zatti, D.; Paul, P.; et al. Engraftment potential of human amnion and chorion cells derived from term placenta. Transplantation 2004, 78, 1439-1448.
133. Weiss, M.L.; Mitchell, K.E.; Hix, J.E.; Medicetty, S.; El-Zarkouny, S.Z.; Grieger, D.; Troyer, D.L. Transplantation of porcine umbilical cord matrix cells into the rat brain. Exp. Neurol. 2003, 182, 288-299.
134. Liao, W.; Xie, J.; Zhong, J.; Liu, Y.; Du, L.; Zhou, B.; Xu, J.; Liu, P.; Yang, S.; Wang, J.; et al. Therapeutic effect of human umbilical cord multipotent mesenchymal stromal cells in a rat model of stroke. Transplantation 2009, 87, 350-359.
135. Medicetty, S.; Bledsoe, A.R.; Fahrenholtz, C.B.; Troyer, D.; Weiss, M.L. Transplantation of pig stem cells into rat brain: Proliferation during the first 8 weeks. Exp. Neurol. 2004, 190, 32-41.
136. Ennis, J.; Gotherstrom, C.; Le Blanc, K.; Davies, J.E. In vitro immunologic properties of human umbilical cord perivascular cells. Cytotherapy 2008, 10, 174-181.
137. Hatlapatka, T.; Moretti, P.; Lavrentieva, A.; Hass, R.; Marquardt, N.; Jacobs, R.; Kasper, C. Optimization of culture conditions for the expansion of umbilical cord-derived mesenchymal stem or stromal cell-like cells using xeno-free culture conditions. Tissue Eng. Part C Methods 2011, 17, 485-493.
138. Girdlestone, J.; Limbani, V.A.; Cutler, A.J.; Navarrete, C.V. Efficient expansion of mesenchymal stromal cells from umbilical cord under low serum conditions. Cytotherapy 2009, 11, 738-748.
139. Yoo, K.H.; Jang, I.K.; Lee, M.W.; Kim, H.E.; Yang, M.S.; Eom, Y.; Lee, J.E.; Kim, Y.J.; Yang, S.K.; Jung, H.L.; et al. Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues. Cell Immunol. 2009, 259, 150-156.
140. Ramasamy, R.; Tong, C.K.; Yip, W.K.; Vellasamy, S.; Tan, B.C.; Seow, H.F. Basic fibroblast growth factor modulates cell cycle of human umbilical cord-derived mesenchymal stem cells. Cell Prolif. 2012, 45, 132-139.
141. Cutler, A.J.; Limbani, V.; Girdlestone, J.; Navarrete, C.V. Umbilical cord-derived mesenchymal stromal cells modulate monocyte function to suppress t cell proliferation. J. Immunol. 2010, 185, 6617-6623.
142. Che, N.; Li, X.; Zhou, S.; Liu, R.; Shi, D.; Lu, L.; Sun, L. Umbilical cord mesenchymal stem cells suppress b-cell proliferation and differentiation. Cell Immunol. 2012, 274, 46-53.
143. Kronsteiner, B.; Peterbauer-Scherb, A.; Grillari-Voglauer, R.; Redl, H.; Gabriel, C.; van, G.M.; Wolbank, S. Human mesenchymal stem cells and renal tubular epithelial cells differentially influence monocyte-derived dendritic cell differentiation and maturation. Cell Immunol. 2011, 267, 30-38.
144. Jiang, X.X.; Zhang, Y.; Liu, B.; Zhang, S.X.; Wu, Y.; Yu, X.D.; Mao, N. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 2005, 105, 4120-4126.
145. Nauta, A.J.; Kruisselbrink, A.B.; Lurvink, E.; Willemze, R.; Fibbe, W.E. Mesenchymal stem cells inhibit generation and function of both cd34+-derived and monocyte-derived dendritic cells. J. Immunol. 2006, 177, 2080-2087.
146. Ramasamy, R.; Fazekasova, H.; Lam, E.W.; Soeiro, I.; Lombardi, G.; Dazzi, F. Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle. Transplantation 2007, 83, 71-76.
147. van den Berk, L.C.; Roelofs, H.; Huijs, T.; Siebers-Vermeulen, K.G.; Raymakers, R.A.; Kogler, G.; Figdor, C.G.; Torensma, R. Cord blood mesenchymal stem cells propel human dendritic cells to an intermediate maturation state and boost interleukin-12 production by mature dendritic cells. Immunology 2009, 128, 564-572.
148. Kermani, A.J.; Fathi, F.; Mowla, S.J. Characterization and genetic manipulation of human umbilical cord vein mesenchymal stem cells: Potential application in cell-based gene therapy. Rejuvenation Res. 2008, 11, 379-386.
149. Liang, X.J.; Chen, X.J.; Yang, D.H.; Huang, S.M.; Sun, G.D.; Chen, Y.P. Differentiation of human umbilical cord mesenchymal stem cells into hepatocyte-like cells by htert gene transfection in vitro. Cell. Biol. Int. 2012, 36, 215-221.
150. The U.S. National Institutes of Health and the National Library of Medicine, Clinicaltrials. Gov: A database of clinical studies of human participants. Website online: http://clinicaltrials.gov/ct2/home (accessed on 22 August 2012)
151. The U.S. National Institutes of Health and the National Library of Medicine, Clinicaltrials. Gov identifier: Nct01291329. Available on line: http://clinicaltrials.gov/ct2/home (accessed on 22 August 2012)
152. Breymann, C.; Schmidt, D.; Hoerstrup, S.P. Umbilical cord cells as a source of cardiovascular tissue engineering. Stem. Cell. Rev. 2006, 2, 87-92.
153. Hua, J.; Qiu, P.; Zhu, H.; Cao, H.; Wang, F.; Li, W. Multipotent mesenchymal stem cells (mscs) from human umbilical cord: Potential differentiation of germ cells. Afr. J. Biochem. Res. 2011, 5, 113-123.
154. Hilfiker, A.; Kasper, C.; Hass, R.; Haverich, A. Mesenchymal stem cells and progenitor cells in connective tissue engineering and regenerative medicine: Is there a future for transplantation? Langenbecks Arch. Surg. 2011, 396, 489-497